These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 31966687)

  • 41. miR-148a-3p Suppresses the Proliferation and Invasion of Esophageal Cancer by Targeting DNMT1.
    Wang Y; Hu Y; Guo J; Wang L
    Genet Test Mol Biomarkers; 2019 Feb; 23(2):98-104. PubMed ID: 30735457
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of direct target genes of miR-7, miR-9, miR-96, and miR-182 in the human breast cancer cell lines MCF-7 and MDA-MB-231.
    Moazzeni H; Najafi A; Khani M
    Mol Cell Probes; 2017 Aug; 34():45-52. PubMed ID: 28546132
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MicroRNA-100 suppresses the migration and invasion of breast cancer cells by targeting FZD-8 and inhibiting Wnt/β-catenin signaling pathway.
    Jiang Q; He M; Guan S; Ma M; Wu H; Yu Z; Jiang L; Wang Y; Zong X; Jin F; Wei M
    Tumour Biol; 2016 Apr; 37(4):5001-11. PubMed ID: 26537584
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MicroRNA-148a is silenced by hypermethylation and interacts with DNA methyltransferase 1 in hepatocellular carcinogenesis.
    Long XR; He Y; Huang C; Li J
    Int J Oncol; 2014 Jun; 44(6):1915-22. PubMed ID: 24714841
    [TBL] [Abstract][Full Text] [Related]  

  • 45. miR-148a promotes cell sensitivity through downregulating SOS2 in radiation-resistant non-small cell lung cancer cells.
    Zhang Y; Hu X
    Oncol Lett; 2022 Apr; 23(4):135. PubMed ID: 35251354
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MiR-148a, a microRNA upregulated in the WNT subgroup tumors, inhibits invasion and tumorigenic potential of medulloblastoma cells by targeting Neuropilin 1.
    Yogi K; Sridhar E; Goel N; Jalali R; Goel A; Moiyadi A; Thorat R; Panwalkar P; Khire A; Dasgupta A; Shetty P; Shirsat NV
    Oncoscience; 2015; 2(4):334-48. PubMed ID: 26097868
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Analysis of a miR-148a Targetome in B Cell Central Tolerance.
    Ma F; Zhan Y; Bartolomé-Cabrero R; Ying W; Asano M; Huang Z; Xiao C; González-Martín A
    Front Immunol; 2022; 13():861655. PubMed ID: 35634349
    [TBL] [Abstract][Full Text] [Related]  

  • 48. RALBP1 regulates oral cancer cells via Akt and is a novel target of miR-148a-3p and miR-148b-3p.
    Ieong C; Ma J; Lai W
    J Oral Pathol Med; 2019 Nov; 48(10):919-928. PubMed ID: 31336396
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Significance of miR-148a in Colorectal Neoplasia: Downregulation of miR-148a Contributes to the Carcinogenesis and Cell Invasion of Colorectal Cancer.
    Hibino Y; Sakamoto N; Naito Y; Goto K; Oo HZ; Sentani K; Hinoi T; Ohdan H; Oue N; Yasui W
    Pathobiology; 2015; 82(5):233-41. PubMed ID: 26389729
    [TBL] [Abstract][Full Text] [Related]  

  • 50. PTK6 inhibition promotes apoptosis of Lapatinib-resistant Her2(+) breast cancer cells by inducing Bim.
    Park SH; Ito K; Olcott W; Katsyv I; Halstead-Nussloch G; Irie HY
    Breast Cancer Res; 2015 Jun; 17(1):86. PubMed ID: 26084280
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MicroRNA-335 suppresses the proliferation, migration, and invasion of breast cancer cells by targeting EphA4.
    Dong Y; Liu Y; Jiang A; Li R; Yin M; Wang Y
    Mol Cell Biochem; 2018 Feb; 439(1-2):95-104. PubMed ID: 28795314
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MiR-15/16 complex targets p70S6 kinase 1 and controls cell proliferation in MDA-MB-231 breast cancer cells.
    Janaki Ramaiah M; Lavanya A; Honarpisheh M; Zarea M; Bhadra U; Bhadra MP
    Gene; 2014 Dec; 552(2):255-64. PubMed ID: 25261849
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ERRATUM.
    Zhao M; Su Z; Zhang S; Zhuang L; Xie Y; Li X
    Oncol Res; 2017 Jan; 25(1):155. PubMed ID: 28081744
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regulation of laryngeal squamous cell cancer progression by the lncRNA H19/miR-148a-3p/DNMT1 axis.
    Wu T; Qu L; He G; Tian L; Li L; Zhou H; Jin Q; Ren J; Wang Y; Wang J; Kan X; Liu M; Shen J; Guo M; Sun Y
    Oncotarget; 2016 Mar; 7(10):11553-66. PubMed ID: 26872375
    [TBL] [Abstract][Full Text] [Related]  

  • 55. miR-148a inhibits cell proliferation and migration through targeting ErbB3 in colorectal cancer.
    Zhao W; Zheng J; Wei G; Yang K; Wang G; Sun X
    Oncol Lett; 2019 Sep; 18(3):2530-2536. PubMed ID: 31402949
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Role of Mir-148a in Cancer.
    Li Y; Deng X; Zeng X; Peng X
    J Cancer; 2016; 7(10):1233-41. PubMed ID: 27390598
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MicroRNA-148a represents an independent prognostic marker in bladder cancer.
    Ma L; Xu Z; Xu C; Jiang X
    Tumour Biol; 2016 Jun; 37(6):7915-20. PubMed ID: 26700670
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 53BP1 suppresses epithelial-mesenchymal transition by downregulating ZEB1 through microRNA-200b/429 in breast cancer.
    Kong X; Ding X; Li X; Gao S; Yang Q
    Cancer Sci; 2015 Aug; 106(8):982-9. PubMed ID: 26011542
    [TBL] [Abstract][Full Text] [Related]  

  • 59. miR-148a-3p represses proliferation and EMT by establishing regulatory circuits between ERBB3/AKT2/c-myc and DNMT1 in bladder cancer.
    Wang X; Liang Z; Xu X; Li J; Zhu Y; Meng S; Li S; Wang S; Xie B; Ji A; Liu B; Zheng X; Xie L
    Cell Death Dis; 2016 Dec; 7(12):e2503. PubMed ID: 27906180
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MicroRNA-146a inhibits cell migration and invasion by targeting RhoA in breast cancer.
    Liu Q; Wang W; Yang X; Zhao D; Li F; Wang H
    Oncol Rep; 2016 Jul; 36(1):189-96. PubMed ID: 27175941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.